Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2019-10-01 2019-09-19
Drug Identification Number 01977547 01977547
Brand name DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP
Common or Proper name DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients DEXAMETHASONE PHOSPHATE DEXAMETHASONE PHOSPHATE
Strength(s) 4MG 4MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRA-ARTICULAR INTRAMUSCULAR INTRAVENOUS INTRA-ARTICULAR INTRAMUSCULAR INTRAVENOUS
Packaging size 1 VIAL 1 VIAL
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-09-18 2019-09-18
Estimated end date 2019-10-01 2019-10-01
Actual end date 2019-09-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Stock is available at McKesson. Stock is available at McKesson.
Health Canada comments